These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8698283)

  • 1. Clinical aspects of biclonal myelomas.
    Goranov S
    Folia Med (Plovdiv); 1994; 36(4):31-6. PubMed ID: 8698283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
    Bladé J; Kyle RA
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the immunological variant in patients with multiple myeloma.
    Goranova V; Spassov E
    Folia Med (Plovdiv); 1999; 41(1):164-7. PubMed ID: 10462951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study.
    Jurczyszyn A; Gozzetti A; Gdula-Argasińska J; Czepiel J; Vij R; Fiala M; Valls DJ; Mądry K; Waszczuk-Gajda A; Grosicki S; Barchnicka A; Crusoe E; Hungria V; Gentile M; Mele G; Ksieniewicz M; Vesole DH; Castillo JJ
    Ann Hematol; 2017 Oct; 96(10):1693-1698. PubMed ID: 28766002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical aspects of biclonal gammopathies. Review of 57 cases.
    Kyle RA; Robinson RA; Katzmann JA
    Am J Med; 1981 Dec; 71(6):999-1008. PubMed ID: 6797297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
    Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S
    Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin heavy and light chain isotypes in multiple myeloma patients.
    Ansari NA; Owais M; Usha
    Asian Pac J Cancer Prev; 2007; 8(4):593-6. PubMed ID: 18260735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kappa and lambda light chain proteins--clinical and prognostic significance in patients with multiple myeloma.
    Goranov S
    Folia Med (Plovdiv); 1997; 39(2):52-7. PubMed ID: 9314667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
    Jiwani S; Bornhost J; Alapat D
    Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations of multiple myeloma: relation to class and type M component.
    Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):896-7. PubMed ID: 817790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal gammapathies. (Critical review of 219 cases collected over 3 years)].
    Youinou P; Le Goff P; Saleun JP; Jouquan J; Tymen G; Le Menn G
    Pathol Biol (Paris); 1977 Oct; 25(8):517-21. PubMed ID: 413086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma presenting as localized expansile jaw tumour.
    Raubenheimer EJ; Lello GE; Dauth J; Fayman MS; Dvornak N; Senekal JC
    Int J Oral Maxillofac Surg; 1988 Dec; 17(6):382-5. PubMed ID: 3145955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
    Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P
    Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy.
    Pradhan D; Arora P; Gami A; Kaur N
    J Cancer Res Ther; 2015; 11(3):660. PubMed ID: 26458669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcomes in biclonal gammopathies.
    Mullikin TC; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lin Y; Dingli D; Go RS; Hayman SR; Zeldenrust SR; Russell SJ; Lust JA; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
    Am J Hematol; 2016 May; 91(5):473-5. PubMed ID: 26840395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
    Singh G
    Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
    Chepovetsky J; Chari A; Jagannath S; Ramanthan L
    Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelomas without serum and urinary monoclonal immunoglobulins - review of pathogenic concepts].
    Fernandes BL
    Acta Med Port; 1983 Jun; 4(6):275-7. PubMed ID: 6351548
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration.
    Dahl IM; Turesson I; Holmberg E; Lilja K
    Blood; 1999 Jun; 93(12):4144-8. PubMed ID: 10361111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.